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Abstract
L. pneumophila is the causative agent of Legionnaires’ disease, a human illness character-
ized by severe pneumonia. In contrast to those derived from humans, macrophages derived
from most mouse strains restrict L. pneumophila replication. The restriction of L. pneumo-
phila replication has been shown to require bacterial flagellin, a component of the type IV
secretion system as well as the cytosolic NOD-like receptor (NLR) Nlrc4/ Ipaf. These events
lead to caspase-1 activation which, in turn, activates caspase-7. Following caspase-7 acti-
vation, the phagosome-containing L. pneumophila fuses with the lysosome, resulting in the
restriction of L. pneumophila growth. The LegS2 effector is injected by the type IV secretion
system and functions as a sphingosine 1-phosphate lyase. It is homologous to the eukary-
otic sphingosine lyase (SPL), an enzyme required in the terminal steps of sphingolipid
metabolism. Herein, we show that mice Bone Marrow-Derived Macrophages (BMDMs) and
human Monocyte-Derived Macrophages (hMDMs) are more permissive to L. pneumophila
legS2mutants than wild-type (WT) strains. This permissiveness to L. pneumophila legS2 is
neither attributed to abolished caspase-1, caspase-7 or caspase-3 activation, nor due to the
impairment of phagosome-lysosome fusion. Instead, an infection with the legS2mutant
resulted in the reduction of some inflammatory cytokines and their corresponding mRNA;
this effect is mediated by the inhibition of the nuclear transcription factor kappa-B (NF-κB).
Moreover, BMDMs infected with L. pneumophila legS2mutant showed elongated mitochon-
dria that resembles mitochondrial fusion. Therefore, the absence of LegS2 effector is asso-
ciated with reduced NF-κB activation and atypical morphology of mitochondria.
Introduction
The facultative intracellular pathogen L. pneumophilamultiplies within human alveolar mac-
rophages and modulates host cell signaling. Following internalization by macrophages or
amoeba, L. pneumophila form a unique compartment called the Legionella containing vacuole
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(LCV) that evades fusion with lysosomes [1–7]. The LCV provides the bacteria with a protected
environment in which L. pneumophila can secure replication. The Dot/Icm type IV secretion
system, which translocates effector proteins into the host cell cytoplasm and manipulates host
cell signaling, coordinates the formation of the LCV [7–9]. Several injected effectors have been
previously identified as substrates of the Dot/Icm secretion system [10–14]. Some effectors are
involved in the recruitment of the endoplasmic reticulum vesicles to the LCV and thus disrupt-
ing host trafficking [15–20]. Others are modulators of the NF-κB pathway [20,21]. Some pro-
teins are homologous to eukaryotic proteins and have domains with enzymatic activity
required in various post-translational modifications, including phosphorylation, glycosylation,
methylation, prenylation, AMPylation and ubiquitination, of host cell proteins [14,20,22–26].
The subcellular compartments in eukaryotic cells are designated by their lipids and proteins
content. Trafficking is tightly controlled to guarantee the correct delivery of cargo to the correct
compartment [27]. For example, phosphatidylinositol 4- phosphate PtdIns (4)P and phospha-
tidylinositol 3- phosphate PtdIns (3)P have been shown to regulate phagolysosome biogenesis
[28]. Some L. pneumophila secreted effectors anchor to the cytoplasmic face of the LCV mem-
brane by binding to phosphoinositide (PI) lipids [29]. This process is achieved through the
modulation of the vacuole membrane PI pattern such as the accumulation of PtdIns (4)P,
which is catalyzed by L. pneumophila effector proteins that directly manipulate PIs or indirectly
control them through effectors that recruit host PI-metabolizing enzymes [27,29]. Moreover,
L. pneumophila largely controls the localization of secreted bacterial effectors and the recruit-
ment of host factors by modulating the PI patterns at the LCV.
The legS2 (lpg2176) was identified in a bioinformatics screen of the L. pneumophila Phila-
delphia-1 genome and encodes for a protein that is highly homologous to the eukaryotic sphin-
gosine 1-phosphate lyase [30,31]. LegS2 exhibits 36% identity and 52% similarity to
Tetrahymena thermophila SPL and functions as a sphingosine 1-phosphate lyase [31]. The L.
pneumophila SPL harbors a C-terminal domain that is required for translocation to eukaryotic
cells via the Icm/Dot system [31]. This domain is absent in the eukaryotic homologues.
SPL is required for the degradation of Sphingosine-1-Phosphate S1P to phosphoethanola-
mine and hexadecanal in eukaryotic cells [31]; Sphingosine-1-Phosphate S1P is a sphingolipid
metabolite that regulates cell migration, angiogenesis, and development [32]. The intracellular
pool of S1P is regulated by three highly conserved enzymes: sphingosine kinase (SPHK) that
catalyzes the phosphorylation of sphingosine producing S1P, S1P phosphatase (S1PP) that
reverses the former reaction, and S1P lyase (SPL) that catalyzes the irreversible cleavage of S1P
to ethanolamine phosphate and a long chain aldehyde [32].
In this study, we show that L. pneumophila lacking the sphingosine-1-phosphate lyase, legS2
replicated in higher numbers compared to WT strain in WT BMDMs. The increase in bacterial
multiplication is not attributed to the compromised activation of caspase-1, caspase-7, or cas-
pase-3 or phagosome lysosome fusion. Instead, the disruption of L. pneumophila SPL is associ-
ated with a reduction in the level of inflammatory cytokines. This reduction results from the
inhibition of the NF-κB pathway. Moreover, infection with the legS2mutant results in an elon-
gation of the mitochondria that is a characteristic of mitochondrial fusion.
Materials and Methods
Ethics statements
This study was carried out in strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institute of health and The Ohio State
University. The Institutional Animal Care and Use Committee (IACUC) has approved our
Animal Use Protocol (AUP), 2010A00000066-R1 and approved this study. Approved by
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Donna McCarthy Beckett, Ph.D., R.N., F.A.A.N. Human cells were obtained from anonymous
samples from the Red Cross, http://www.redcrossblood.org/centralohio. Blood from the red
cross does not have any information or link to the donor and therefore does not require IRB or
consent. Primary macrophages derived from mice bone marrow were used.
Bacterial strains
L. pneumophila JR32 [33] and the legS2mutant [30] were kindly provided by Dr. Amal Amer,
at The Ohio State University. L. pneumophila strains were grown on buffered charcoal yeast
extract solid media (BCYE) plates at 37°C, or in BYE broth containing L-cysteine, thymidine
and ferric nitrate supplements at 37°C with shaking [2,34].
Mice, cell culture and infections
Wild-type mice were purchased from Jackson laboratory. Mice were housed in AALAC-
accredited facilities and kept in ventilated cages with automatic water valves (lixit). Mice were
fed Harlan 7912 as needed and kept in 12hr light/dark cycles 6am-6pm light, 6pm-6am—dark
for their circadian rhythms. Plastic houses/huts were provided for enrichment if one mouse
per cage or mice needed to feel more secure. Mice were euthanized by CO2 then cervical dislo-
cation. Anesthesias for in vivo experiments were done by exposing the mice to isoflurane gas
for 30 seconds until they are asleep. Mice were monitored daily for signs of pain or distress. All
of the animals received humane care according to the criteria outlined in the Guide for the
Care and Use of Laboratory Animals published by National Institutes of Health and The Ohio
State University. C57BL/6 BMDMs were prepared from the femurs of five to eight-week-old
mice as previously described [2,35] and grown in IMDM (Iscove’s modified Dulbecco’s
medium supplemented with the L929 fibroblast cell line (ATCC)-cultured supernatant and
10% heat inactivated fetal bovine serum (HIFBS) (Gibco). Infection was done in IMDM sup-
plemented with 10% HIFBS. The isolation and preparation of the hMDMs from peripheral
blood (obtained from the Red Cross) was carried out as previously described [34,36,37].
In vitro and in vivo infection
The in vitro BMDM infections were carried with a multiplicity of infection (MOI) of 0.2–0.5
unless otherwise specified. For in vivo experiments, C57BL/6 mice were infected with 1x106
bacteria intratracheally. The lungs were harvested 4 or 48 h post-infection, homogenized, and
plated on BCYE with streptomycin. Colony forming units (CFUs) were then quantified.
Western blot
Cell extracts were prepared and immunoblotted with antibodies that recognize caspase-1, cas-
pase-7 and caspase-3 (Cell Signaling), followed by the appropriate secondary antibody. Equal
concentration of protein was loaded on a 12% SDS polyacrylamide gel.
Macrophage cytotoxicity assay
In vitro quantification of cytoplasmic histone-associated-DNA-fragments (apoptosis) was per-
formed using the Cell Death Detection ELISA and the photometric enzyme immunoassay
(Roche Applied Science) according to the manufacturer’s specifications. The fold change of
macrophage necrosis was determined by measuring the release of host cell cytoplasmic lactate
dehydrogenase (LDH) using the cytotoxicity detection kit (Roche Applied Science) according
to the manufacturer’s specifications. BMDMs (0.5 x 106) were plated in 12-well plates and
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infected with either JR32 or the legS2mutant at an MOI of 0.5, 1, or 5. The supernatants were
then collected 24 h post-infection and assayed.
NF-κB DNA binding activity assay
Nuclear extracts of WT BMDMs untreated or treated with the JR32 or legS2mutant were pre-
pared as described [2]. EMSA was used to measure NF-κB DNA binding activity as noted [38].
Lyso tracker red colocalization
Wild-type mouse macrophages were plated at a density of 0.5 x 106 cells per well in a 24 well
plate containing sterile coverslips for 48 h. The lyso tracker red was added to the monolayer for
30 min at 37°C. The monolayer was then washed with the infection medium 3 times and kept
for 30 min at 37°C in infection media alone. Next, it was infected with JR32, dotA, or legS2 at
an MOI of 0.2 for 1 h. Then, the monolayer was washed with the infection medium, fixed with
paraformaldehyde, and finally stained with the anti-L. pneumophila antibody, followed by the
secondary antibody Alexa flour 488 goat anti-mouse. The coverslips were mounted and viewed
by the Olympus FV1000 spectral Confocal Laser Scanning Microscopy (CLSM).
Enzyme-linked immuno sorbent assay (ELISA)
Macrophages were infected with L. pneumophila JR32 or the legS2mutant for 24 h. Then, cul-
ture supernatants were collected, centrifuged and stored at -20°C until assayed for cytokine
content. The amount of IL-1β, IL-6, IL10 and TNFα in the supernatants was determined by
specific sandwich ELISA following the manufacturer’s protocol (R&D system Inc.,
Quantitative PCR
Total RNA was extracted from mouse macrophages using Trizol (Invitrogen Life Technolo-
gies). Then, 1–2 μg of the RNA were converted to cDNA by ThermoScript RNase H- Reverse
Transcriptase (Invitrogen, Life Technologies). 20–60 ng of the converted cDNA was used for
quantitative PCR with SYBR Green I PCR Master Mix in the Step One Plus Real Time PCR
System (Applied Biosystems). The target gene Ct values were normalized to the Ct values of
two housekeeping genes (human GAPDH and CAP-1, accordingly to the cell origin) and
expressed as relative copy number (RCN) (34).
Transmission Electron Microscopy
BMDMs were plated at a density of 4x106 per well on coverslips in Permanox chamber slides,
with 2 chambers and 8 units per tray (lab tech) for 48 h; they were then infected with an MOI
of 1 for 4 h or MOI of 0.5 for 24 h. The coverslips were fixed with 2.5% glutaraldehyde in 0.1M
phosphate buffer and 0.1M sucrose at a pH of 7.4. The cells were post-fixed with 1% osmium
tetroxide in the phosphate buffer; then, they were en bloc stained with 2% uranyl acetate in
10% ethanol, dehydrated in a graded series of ethanol, and embedded in Eponate 12 epoxy
resin (Ted Pella Inc., 18012). Ultrathin sections were cut on a Leica EM UC6 ultramicrotome
(Leica microsystems, EM FC7), collected on copper grids and stained. Images were acquired
with an FEI Technai G2 Spirit transmission electron microscope (FEI), a Macrofire (Optronics)
digital camera, and AMT image capture software.
Statistical analysis
The comparisons of groups for statistical difference were done using a Student’s two-tailed t-
test. P values less than 0.05 were considered significant.
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Results
L. pneumophila legS2 strain replicates in WT BMDMs and hMDMs
To delineate the role of LegS2 in L. pneumophila infection, we tested the replication of the JR32
and legS2mutant in WT BMDMs. The BMDMs restricted the growth of the JR32 strain, while
the legS2mutant showed a 10- fold increase in the colony forming units (CFUs) over time (48–
72 h) compared to the JR32 strain (Fig 1A). Since humans are permissive to L. pneumophila
replication (39), we also examined the intracellular growth of legS2mutant in hMDMs (Fig
1B). Both JR32 and legS2mutant replicated in hMDMs; however, the legS2mutant replicated
more than the JR32 strain.
Legionnaires’ disease stems from the successful replication of L. pneumophila in human
alveolar macrophages [39,40]. Therefore, we tested legS2 mutant replication in vivo by
examining the bacterial CFUs within the lungs of infected mice. C57BL/6 mice were
infected with either 1x106 JR32 or legS2mutant intratracheally. The initial bacterial load
was not significantly different 4 h post-infection (Fig 1C). However, 48 h post-infection, the
legS2 mutant-infected mice harbored 4 fold more CFUs compared to the JR32 strain (Fig
1D). Our data showed that the legS2 mutant replicates in WT mice and their derived
macrophages.
Fig 1. L. pneumophila legS2mutant replicates in humanMDMs and wild-typemice and their derived
macrophages. A) BMDMs were infected with wild-type L. pneumophila, JR32, or ΔlegS2 for 1, 24, 48 and
72h. The colony forming units (CFUs) were scored at the indicated time points. B) hMDMs were infected with
wild-type L. pneumophila, JR32, or ΔlegS2 for 1, 24, 48 and 72h. Data are shown as mean + SD of n = 3.
Asterisks indicate significant differences, and a two tailed t-test was used to calculate the P value (*P<0.05,
**P<0.01, ***P<0.001). (C and D) Four female C57BL/6 mice per group received 1x106 of JR32 or legs2
bacteria intratracheally. Lungs were homogenized and plated for CFUs, counting at (C) 4 or (D) 48 h post
infection. (C and D) Data are shown as mean + SD of four mice. Asterisks indicate significant differences
(***P<0.001); a two tailed t-test was used to calculate the P-value.
doi:10.1371/journal.pone.0146410.g001
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The growth of legs2mutant is independent of caspase-1 or caspase-7
activation
Caspase-1 activates caspase-7, resulting in the restriction of L. pneumophila growth by mediat-
ing the fusion of the LCV to the lysosome [41–43]. Casp-1-/- BMDMs are permissive to L.
pneumophila replication [2]. Therefore, impaired caspase-1 activation could result in the
increased replication of the legS2mutant. Therefore, we examined the replication of legS2
mutant bacteria in Casp-1-/- BMDMs. The legS2mutant showed higher replication than JR32
24, 48, and 72 h post-infection in casp-1-/-BMDMs (Fig 2A). Since the cleavage and maturation
of IL-1β is mediated by caspase-1 activation, we examined the level of IL-1β 24 h post-infection
with the JR32 or the legS2mutant by ELISA. No significant differences were seen in the level of
IL-1β 24 h post-infection with either the JR32 or the legS2mutant (Fig 2B). Moreover, we
tested the possibility of differential activation of caspase-1 by the WT JR32 or legS2mutant.
Indeed, both JR32 and legS2 infected BMDMs showed capsase-1 cleavage as detected by the
mature subunits of casp-1 (Fig 2C). Taken together, the replication of the legS2mutant in WT
macrophages is independent of caspase-1 activation.
The growth restriction of L. pneumophila is also attributed to caspase-7 mediated bacterial
delivery to the lysosome and the early death of murine macrophages [2,44]. Hence, impaired
caspase-7 activation could result in increased replication of the legS2mutant. To that end, we
assessed the activation of caspase-7 by Western blot. Both the JR32 and the legS2mutant
cleaved caspase-7 in WT macrophages (Fig 2D). Thus, the replication of the legS2mutant is
independent of caspase-1 or caspase-7 activation.
Fig 2. The permissiveness of mice BMDMs to legS2mutant bacteria is independent of caspase-1 or
caspase-7 activation. (A) Caspase-1 KO (casp-1-/-) macrophages were infected with L. pneumophila, JR32,
or legS2 with an MOI of 0.5 for 1, 24, 48 and 72 h; then, CFUs were measured at the indicated time points. (B)
Levels of IL-1β were detected in supernatants of WT or casp-1-/- BMDMs were infected with JR32 or the
legS2mutant after 24 hr, while WT BMDMs were either not treated (NT) or infected with L. pneumophila,
JR32, or legS2mutant bacteria for 2 h. Salmonella infection (Sal) was used as a positive control for caspase-
1 or caspase-7 activation. (C) Casp-1 or (D) casp-7 antibodies were used to detect casp-1 and casp-7
activation, respectively, in cell extracts.
doi:10.1371/journal.pone.0146410.g002
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The growth of legs2mutant is independent of host cell death
Interference with the host’s survival is a key determinant in the L. pneumophila replication cycle.
Early cell death aborts L. pneumophila replication and terminates the infection [45]. It is possible
that the legS2mutant modulates the macrophage’s life span to sustain its replication. To dissect
the role of LegS2 in mediating host cell death, we quantified the level of LDH released in the cul-
ture supernatants of macrophages infected with either JR32 or the legS2mutant. Comparable
LDH release was observed in the culture supernatants of both the JR32 and the legS2mutant-
infected macrophages at the two different MOIs (Fig 3A). Moreover, we measured apoptosis in
the overall population of macrophages by determining the cytoplasmic apoptosis histone-associ-
ated-DNA fragments at MOIs of 0.5, 1 and 5. We found that infection by JR32 and the legS2
mutant leads to comparable cell death at both low and highMOIs (Fig 3B). Overall, our data
demonstrates that the replication of the legS2mutant in macrophages is independent of cell
death. Further, the activation of caspase-3 is comparable in JR32 and legS2 infected macrophages
(Fig 3C). Consequently, the replication of the legS2mutant is independent of host cell death.
The replication of the legS2mutant in WT BMDM is not attributed to
impaired phagosome-lysosome maturation
The restriction of L. pneumophila in WT BMDMs is dependent upon the delivery of the LCV
to the lysosome, which ultimately results in bacterial degradation. To determine the mecha-
nism by which the legS2mutant bacteria replicate in macrophages, we examined the colocaliza-
tion of the JR32, dotA, and legS2mutants with lyso- tracker Red, an acidic dye used to track the
lysosome. (Fig 4A) shows images obtained by the Confocal Laser Scanning Microscopy
(CLSM), and (Fig 4B) shows the score of the percentage of bacteria colocalized within the lyso-
tracker positive compartment. Approximately 60% of the translocation-defective dotAmutant
was delivered to the lyso tracker-labeled compartment within 1 h of infection. In addition, 52%
Fig 3. Replication of legS2mutant is independent of host cell death. (A) Wild-type BMDMs were not
treated (NT) or infected with the type IV secretion mutant dotA, wild-type L. pneumophila, JR32, or legS2
mutant for 24h at MOIs of 0.5 and 5. Then, the fold change in LDH release was measured from the overall
population of macrophages. The data represents the mean + SD of n = 3. (B) Wild-type C57BL/6 (B6) were
not treated (NT) or infected with wild-type L. pneumophila, JR32, legS2, or dotAmutant for 8 h. Salmonella
infection (Sal) was used as a positive control for caspase-3 activation. A Western blot with caspase-3
antibody was used to detect casp-3 activation. β-actin was used as a loading control.
doi:10.1371/journal.pone.0146410.g003
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of the JR32 were destined to the lyso tracker labeled compartment. This is due to the fact that
WT cells are restrictive to L. pneumophila replication. The trafficking of the legS2mutant was
comparable to that of the JR32 with ~57% lyso tracker labeled compartment. Therefore, the
legS2mutant’s substantial replication in WTmacrophages is not attributed to enhanced eva-
sion of LCV-lysosome fusion.
The increased replication of the legS2mutant in BMDMs is associated
with reduced cytokine production
The production and secretion of cytokines and chemokines is concomitant with L. pneumo-
phila intracellular growth [46]. Cytokines are chemical mediators that play fundamental roles
in eliciting the necessary immune response for controlling lung infection. We examined the
level of several pro-inflammatory and anti-inflammatory cytokines following infection with
either the JR32 or the legS2mutant by ELISA. After 24 h, the levels of the cytokines IL-10, IL-6,
and TNFα were significantly less in macrophages infected with the legS2mutant as compared
to those infected with JR32. The level of IL-10 in JR32 infected cells was double the amount in
legS2 infected cells, (Fig 5A), the levels of IL-6 and TNFα in JR32 infected cells were triple the
amount in legS2 infected cells, (Fig 5B and 5C). Differences in the cytokine levels were also evi-
dent in the Casp1-/- BMDMs 24 h post-infection. Our data suggested that cytokine production
is associated with increased replication of the legS2mutant in WT BMDMs.
The legS2mutant infected macrophages exhibited reduced cytokine
mRNAs accompanied by inhibition of the NF-κB pathway
To decipher the mechanism by which legS2 affects cytokine level, we used quantitative
RT-PCR to examine the levels of the cytokine mRNA following infection with either the JR32
Fig 4. Replication of L. pneumophila legS2mutant is not due to defective phagosome-lysosome
fusion. (A) Images of wild-type macrophages not infected (NT) or infected with the type IV secretion mutant
dotA, wild-type L. pneumophila, JR32, and the legS2mutant. The first panel presents staining with DAPI, with
arrow heads pointing to the bacteria. The second panel shows staining with the lyso tracker. The third panel
depicts merged images, with bacteria colocalized with the lysosomal marker. B) The percent of bacteria
colocalized with the lyso tracker was scored in 100 infected cells from 3 independent coverslips. The data
represents the mean + SD of n = 3.
doi:10.1371/journal.pone.0146410.g004
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or the legS2mutant. At 4 h post-infection, the transcription levels of IL-10, IL-6 and TNFα
were reduced in the legS2 infected monolayers as compared to the JR32 infected monolayers
(Fig 6A–6C). Our results indicate that the decrease in cytokine level from the legS2 infected
cells was due to lower levels of cytokine mRNA.
NF-κB is a transcription factor that regulates the mammalian innate immune system by
modulating the transcription of pro-inflammatory cytokine and chemokine genes [47]. Indeed,
infection with L. pneumophila activates the host NF-κB pathway [1,48]. Therefore, we exam-
ined NF-κB activation by an electrophoretic mobility shift assay (EMSA) (Fig 7). The EMSA
data showed that, 4–8 h post-infection, NF-κB was inhibited in the legS2mutant and not in the
JR32 strain. This suggests that the reduced cytokine production is associated with the inhibi-
tion of the NF-κB pathway.
Infection with the legS2mutant is accompanied by change in
mitochondrial morphology
The dynamic nature of mitochondrial morphology is shown by its continuously fusing and
interconnecting network [49]. The fusion process is critical for the maintenance of mito-
chondrial function [50]. However, mitochondrial fission is an early event during apoptosis,
either occurring before or coinciding with cytochrome c release [49,51,52]. It is upstream of
caspase activation and characterized by mitochondrial fragmentation into multiple small
units [49,51,52]. We employed transmission electron microscopy to examine cells infected
with either the JR32 or the legS2mutant at 4 and 24 h post-infection (Fig 8). Our data
showed that, 24 h post-infection, BMDMs infected with the legS2mutant exhibited elon-
gated mitochondria that seemed to be fused with each other. In BMDMs infected with the
JR32 strain, however, we observed fragmented mitochondria, indicating fission. These data
suggest that the legS2mutant bacteria manipulate mitochondrial fusion and fission,
respectively.
Fig 5. Increased replication of the legS2mutant in BMDMs is associated with reduced cytokine
production.WT BMDMs or casp-1-/- macrophages were infected with L. pneumophila, JR32, or the legS2
mutant. 24 h post infection, the supernatants from infected and un-infected cells were assayed by ELISA. (A)
IL-10 level, (B) IL-6, (C) TNFα levels. Data represent the mean + SD of n = 3. Asterisks indicate significant
differences (***P<0.001), and a two tailed t-test was used to calculate the P-value.
doi:10.1371/journal.pone.0146410.g005
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Discussion
In summary, we show that the legS2mutant bacteria replicate in WT mice and their derived
macrophages. The permissiveness of BMDMs to infections with the legS2mutant, is accompa-
nied by the dampening of pro-inflammatory and anti-inflammatory cytokines, inhibiting the
NF-κB pathway resulting in changes in mitochondrial morphology.
Studies with the A/J-derived mouse macrophages, which are permissive to L. pneumophila
infection, showed a biphasic activation of NF-κB during infection [1,48,53,54]. The early phase
is characterized by strong but transient activation. Even though this phase is beneficial for the
host cell, it must be dampened quickly to overcome the toxic effect of inflammatory cytokines
[54]. IL-6 and TNFα are major proinflammatory cytokines that are produced in response to
NF-κB activation. They regulate inflammatory responses locally and systemically. Moreover,
they recruit leukocytes and mediate more cytokine production and increased bactericidal activ-
ity [55,56]. The limitation of the above cytokines following infection with the legS2mutant is
likely responsible for the enhanced L. pneumophila growth in vivo. Indeed, patients with
Legionnaires’ disease show increased level of IL-6 and TNFα in their lungs [57–60]. Further-
more, the addition of TNFα renders macrophages less permissive for L. pneumophila and ren-
ders neutrophils more bactericidal [61] [62]. Also, mice with a mutation that abrogates Toll-
like receptors (TLRs) exhibit limited cytokines, which in turn results in increased susceptibility
to L. pneumophila lung infection [63–65]. Therefore, the reduction in the levels of IL-10, IL-6
and TNFα could result in the increased replication of the legS2mutant.
We also observed that infecting BMDMs with legS2mutant results in the reduction of IL-10
level, and other studies have shown that IL-10 is induced in vivo upon L. pneumophila infection
[57,59,66–68]. IL-10 is an anti-inflammatory cytokine that represses the expression of Th1
cytokines [69–71]; therefore, it seems that, by dampening the IL-10, the legS2mutant reduces
L. pneumophila replication. However, it is quite likely that limiting IL-6 and TNFα outweighs
Fig 6. The legS2mutant limits the levels of cytokine mRNAs.WT BMDMs or casp-1-/- macrophages
were infected with L. pneumophila, JR32, or the legS2mutant. 4 h post infection, total RNA was isolated from
JR32 or legS2 infected macrophages; then, the converted cDNA was used for quantitative PCR. The target
gene Ct values were normalized to the Ct values of two housekeeping genes (human GAPDH and CAP-1,
according to the cell origin) and expressed as relative copy numbers (RCN). (A) Represents the IL-10 RCNs,
(B) Represents the IL-6 RCNs, (C) Represents the TNFα RCNs. Data represent the mean + SD of n = 3.
Asterisks indicate significant differences (***P<0.001); a two tailed t-test was used to calculate the P-value.
doi:10.1371/journal.pone.0146410.g006
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the effect of IL-10. Thus, the overall impact of a legS2mutant infection is promoting growth in
BMDMs. Even though we focused our study on IL-6, IL-10, TNFα and IL-1β, it is likely that
legS2 affects other cytokines that are produced by macrophages as well.
Based upon our RT-PCR analysis of IL-6, IL-10 and TNFα in macrophages infected with
legS2mutants, we can conclude that infection with L. pneumophila legS2 dampens the mRNA
Fig 7. The legS2mutant inhibits the NF-κB pathway.Wild-type macrophages were either not treated (NT)
or infected with the JR32, or the legS2mutant for 1, 4, and 8h. Then, nuclear extracts were processed using
electrophoretic mobility shift assay (EMSA) to determine NF-κB activation.
doi:10.1371/journal.pone.0146410.g007
Fig 8. Infection with the legS2mutant is accompanied by change in mitochondrial morphology. TEM of BMDMs infected with the JR32 or the legS2
mutant. Images were taken from 24 h post-infected cells.
doi:10.1371/journal.pone.0146410.g008
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expression of cytokines in infected cells. The reduction in the above cytokines is likely a conse-
quence of the inhibition of the NF-κB pathway seen by EMSA.
Our TEM data show that infection with legS2mutant bacteria results in changes in mito-
chondrial fusion or fission. We observed mitochondrial morphologies that resemble fused
mitochondria in legS2 infected cells. Mitochondrial fusion has been linked to an increase in the
total pool of ATP during starvation [51]. Consistent with our results, Degtyar et. al showed
that legS2 colocalizes to the mitochondria in U937 infected cells [31].
Listeria monocytogenes is another pathogen that has been shown to manipulate mitochon-
drial fusion/fission. The link between mitochondrial dynamics and the efficiency of the L.
monocytogenes infection has been demonstrated. Indeed, the inhibition of the mitochondrial
fusion has been shown to decrease the efficiency of L.monocytogenes infection [72]. Similarly,
inducing mitochondrial fusion the legS2mutant resulted in a more efficient infection than in
the WT. Therefore, modulating mitochondrial fusion/fission by these two pathogens could
impact the efficiency of macrophage infection.
We show that legS2mutant replicated more than the JR32 strain.
It seems contradictory that L. pneumophila would maintain legS2 in the genome, even
though it is dispensable for replication in Acanthamoeba castellanii [31]. It is possible that
retaining redundant genes in the genome of L. pneumophila is a factor utilized during evolution
to prevent chromosomal lesions. Such lesions could affect the ability of the bacteria to multiply
intracellularly [30,73]. Moreover, the survival of L. pneumophila in several protozoan hosts
could improve the hosts’ tropism. However, it could prevent host specialization by retaining
pathways that are essential for growth in macrophages and other hosts. Therefore, growing L.
pneumophila in laboratories or in murine macrophages, which are not the natural host for this
bacteria, could greatly affect the fitness and host range of L. pneumophila [74]. Furthermore,
the restriction of L. pneumophila growth in murine macrophages by the acquisition of legS2
could select for bacteria that has increased adaptability to other hosts.
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